Downloadable Slide Decks

Metastatic Breast Cancer: Enhancing Treatment Tolerability, Adherence, and Patient-Centered Care

In this NCPD activity, Mikel Ross, MSN, RN, AGPCNP-BC, OCN®, CBCN, identifies prognostic markers that impact treatment selection and treatment goals to individual patients with metastatic breast cancer (MBC), evaluates the efficacy and safety profiles of novel therapies for HER2-positive, HER2-negative, and triple-negative MBC, and more. Complete the activity now to earn free NCPD!

Multiple Myeloma: Enhancing Treatment Tolerability, Adherence, and Patient-Centered Care

Self-Study Resource | Nonaccredited

In this free NCPD activity, Beth Faiman, PhD, MSN, APN-BC, AOCN®, discusses tailored treatment selection, novel therapeutic strategies, treatment-related adverse events, and patient-centered care for patients with MM. Speaker slides available for download!

Keeping Pace With Evolving Treatment Paradigms in Advanced Renal Cell Carcinoma: The Nurse’s View

1.0 NCPD | ILNA

This NCPD activity, presented by Laura S. Wood, RN, MSN, OCN, discusses mechanisms of action of IO agents and VEGFR TKIs, efficacy and safety profiles of IO and VEGFR TKI therapies, and strategies to improve treatment tolerability for advanced renal cell carcinoma. Start now!

Exploring Novel Treatment Strategies for Metastatic Colorectal Cancer

Self-Study Resource | Nonaccredited

In this presentation, Jaffer A. Ajani, MD, FASCO, discusses incidence, mortality, novel therapies, individualized treatment and combination treatment strategies for patients with metastatic CRC. Download the slides today!

Clinical Updates and Expert Guidance in Prostate Cancer

Self-Study Resource | Nonaccredited

Judd W. Moul, MD, discusses hormone-sensitive prostate cancer, metastatic CRPC, and nonmetastatic CRPC using a case-based approach. Presentation is available for download!

New Directions in the Management of Relapsed/Refractory Follicular Lymphoma

Self-Study Resource | Nonaccredited

Download the speaker slides for this presentation on personalized care planning and novel therapeutic approaches in relapsed/refractory follicular lymphoma developed by Anas Younes, MD.

New Thinking, New Strategies in the Treatment of Advanced NSCLC Without Driver Mutations

Self-Study Resource | Nonaccredited

This case-based CME-approved presentation on molecular and clinical factors that can inform first- and second-line treatment strategies for patients with NSCLC was developed by Jamie E. Chaft, MD. Download the slides!

New Clinical Perspectives in the Management of Myelofibrosis

Self-Study Resource | Nonaccredited

This presentation discusses prognostic markers that can inform personalized care plans, ermerging data, and the implications of research advances on the treatment of myelofibrosis patients. It was developed by Srdan Verstovsek, MD, PhD, from MD Anderson. Download the complimentary slides!

Oncology Nursing Showdown: Advanced Non-Hodgkin Lymphoma Edition

Self-Study Resource | Nonaccredited

This presentation, led by Amy L. Goodrich, RN, MSN, CRNP-AC, discusses NHL case studies, novel therapies, and adverse event management. Download the speaker slides today.

Optimizing Therapeutic Strategies in Castration-Resistant Prostate Cancer

1.0 CME/NCPD/CPE | VA/DoD Meeting Series

This activity will discuss emerging efficacy and safety data on novel therapies for nmCRPC and mCRPC, strategies to manage adverse events, and the role of imaging studies and PSA testing in evaluating treatment response. Schedule a meeting today!

Defining Personalized Care Plans in Metastatic Colorectal Cancer

1.0 CME | MOC

In this free online CME activity, Tanios S. Bekaii-Saab, MD, uses a case-based approach to discuss prognostic factors that can tailor treatment to individual patients, novel therapies, and optimizing treatment experiences for patients with newly diagnosed and relapsed/refractory metastatic colorectal cancer.

Clinician Resource Guides

Video Viewpoint Strategy Session: Expert Guidance on New Advances in Renal Cell Carcinoma

0.5 CME | 0.5 NCPD | MOC | ILNA

This free online CME/NCPD activity on first-line and second-line treatment for advanced renal cell carcinoma is presented by Bradley McGregor, MD, and Robert Motzer, MD. It is also available as a podcast. Start the activity now!

Video Viewpoint Strategy Session: Expert Guidance on the Treatment of ALK-Positive Advanced Non-Small Cell Lung Cancer

0.5 CME | 0.5 NCPD | ILNA Points

In this CME/NCPD activity, Mark G. Kris, MD, and Nathan Pennell, MD, discuss how the potential for CNS disease and acquired resistance mutations can infuence treatment selection for NSCLC and evaluate the efficacy of novel therapies for NSCLC. Also available as a bonus episode for our Oncology Data Advsior podcast!

Virtual Tumor Board: Optimizing Personalized Care Plans for Patients With Metastatic Breast Cancer

1.0 CME | 1.0 NCPD | MOC | ILNA

In this virtual tumor board, Sara M. Tolaney, MD, MPH, Ira J. Bleiweiss, MD, and Mikel Ross, MSN, RN, AGPCNP-BC, OCN®, CBCN, assess predictive and prognostic markers for MBC, evaluate current and emerging data on therapeutic approaches for HER2-positive, hormone receptor-positive/HER2-negative, and triple-negative MBC, and apply strategies to manage adverse events for MBC. Start now!

Virtual Tumor Board: Optimizing Personalized Care Plans for Patients With Relapsed/Refractory Follicular Lymphoma

1.0 CME | MOC

This CME virtual tumor board, presented by Loretta J. Nastoupil, MD, Reem Karmali, MD, MS, and Francisco Vega, MD, PhD, evaluates emerging efficacy and safety data on novel therapeutic approaches, discusses the implications of POD24 status in therapeutic decision making for patients, and applies strategies to optimize treatment experiences and outcomes for patients with relapsed/refractory FL. Start now!

Virtual Tumor Board: Diagnosis and Management of Myelodysplastic Syndromes

Self-Study Resource | Nonaccredited

In this virtual tumor board, David P. Steensma, MD, FACP, Reza Nejati, MD, and Ilene Galinsky, BSN, MSN, ANP-C, discuss patient and tumor characteristics that inform personalized care plans, risk stratification, and supportive care strategies for patients with MDS. Download the resource guide!

Optimizing Personalized Care Plans for Patients With Advanced Non-Small Cell Lung Cancer

Self-Study Resource | Nonaccredited

Download the NSCLC resource guide for an outline of TNM staging, treatment by cancer stage, initial systemic therapy, emerging biomarkers, targeted therapy, EGFR TKI toxicity, MASCC rash prevention, and survivorship care.

New Directions in the Management of Relapsed/Refractory Follicular Lymphoma

Self-Study Resource | Nonaccredited

This clinician resource guide discusses grading, Ann Arbor classification, diagnostic workup, FLIPI risk factors, personalized care planning, and novel therapeutic approaches for relapsed/refractory FL. Download the guide!

Downloadable Slide Decks

Metastatic Breast Cancer: Enhancing Treatment Tolerability, Adherence, and Patient-Centered Care

Immune Thrombocytopenia: Evolving Treatment Paradigms and Patient-Centered Care

Understanding Evolving Treatment Paradigms in Advanced Hepatocellular Carcinoma

New Thinking, New Strategies in Advanced Urothelial Carcinoma

Multiple Myeloma: Enhancing Treatment Tolerability, Adherence, and Patient-Centered Care

Keeping Pace With Evolving Treatment Paradigms in Advanced Renal Cell Carcinoma: The Nurse’s View

Exploring Novel Treatment Strategies for Metastatic Colorectal Cancer

Clinical Updates and Expert Guidance in Prostate Cancer

New Directions in the Management of Relapsed/Refractory Follicular Lymphoma

New Thinking, New Strategies in the Treatment of Advanced NSCLC Without Driver Mutations

New Clinical Perspectives in the Management of Myelofibrosis

Oncology Nursing Showdown: Advanced Non-Hodgkin Lymphoma Edition

Optimizing Therapeutic Strategies in Castration-Resistant Prostate Cancer

Defining Personalized Care Plans in Metastatic Colorectal Cancer

Clinician Resource Guides

Video Viewpoint Strategy Session: Expert Guidance on New Advances in Renal Cell Carcinoma

Video Viewpoint Strategy Session: Expert Guidance on the Treatment of ALK-Positive Advanced Non-Small Cell Lung Cancer

Virtual Tumor Board: Optimizing Personalized Care Plans for Patients With Metastatic Breast Cancer

Virtual Tumor Board: Optimizing Personalized Care Plans for Patients With Relapsed/Refractory Follicular Lymphoma

Virtual Tumor Board: Diagnosis and Management of Myelodysplastic Syndromes

Optimizing Personalized Care Plans for Patients With Advanced Non-Small Cell Lung Cancer

New Directions in the Management of Relapsed/Refractory Follicular Lymphoma

Company

Resources

Follow Us